• 2004

Company Description

Cytox is developing transformational prognostic technology that may contribute to the assessment of an individual's risk of developing

Cytox is developing transformational prognostic technology that may contribute to the assessment of an individual's risk of developing dementias such as Alzheimer's disease. Cytox Limited - a UK-based company with a unique scientific and proprietary technology platform. Through the application of this fundamental science and our specific know-how, we are elucidating the biology and genetics behind dementia, as well as developing prognostics tests for cognitive decline and individual risk of developing AD or other dementias.